Background-Accurate risk stratification is crucial for effective treatment planning after myocardial infarction (MI).
A lthough left ventricular ejection fraction (LVEF) is currently the most robust clinical parameter in postmyocardial infarction (MI) risk stratification and in guidance of critical treatment decisions such as prophylactic implantation of cardioverter-defibrillators, 1,2 current risk assessment remains suboptimal, and the need for other accurate predictors of outcome is evident. 3, 4 Despite the high success rate of coronary revascularization in recent years, life-threatening ventricular arrhythmias remain an important cause of post-MI mortality. 5, 6 Although dense, fibrous scars in the infarcted myocardium incapable of depolarization cannot alone cause arrhythmias, when surrounded by distorted bundles of surviving myocytes capable of depolarization in the infarct border zone, arrhythmogenic substrates for slow conduction and reentry phenomena may arise. [7] [8] [9] [10] [11] [12] [13] 
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Cardiac magnetic resonance imaging (CMR) represents a valuable noninvasive tool in the assessment and risk stratification of patients with MI. CMR can not only accurately assess LV volumes and function 14 but also detect and quan-tify the extent of both acute and chronic MI. [15] [16] [17] [18] [19] Furthermore, infarct characterization by CMR may have prognostic implications. With high spatial resolution and contrast-to-noise ratio, CMR may allow detailed characterization of infarcts by differentiating the core and peripheral regions. Using necrosis-specific mesoporphyrin and nonspecific, extracellular, gadolinium-DTPA contrast agents in animal studies, Saeed et al 20, 21 demonstrated CMR characterization of the peri-infarct zone that was speculated to contain viable myocardium. Recent preliminary clinical studies with contrastenhanced CMR have reported the associations of infarct size and the peri-infarct zone with inducible ventricular arrhythmias. 22, 23 However, the prognostic significance of the periinfarct zone has not been assessed. Accordingly, the objective of this pilot study was to examine the relation between morphological infarct characteristics, determined by contrastenhanced CMR, and post-MI mortality. We hypothesized that the extent of the peri-infarct border zone is associated with mortality in post-MI patients, independent of LV functional parameters such as LVEF and LV volume indices.
Methods

Patient Population
We enrolled 167 consecutive patients with a history of coronary artery disease who were found to have abnormal myocardial delayed enhancement (MDE) on CMR performed at our institution. A history of coronary artery disease included documented previous MI, coronary artery stenosis Ͼ70% on angiography, prior percutaneous coronary intervention, or coronary artery bypass graft surgery. The primary indications for CMR examination were as follows: assessment of myocardial viability and infarct size (nϭ65), ischemia (nϭ66), LV function and morphology (nϭ6), and others (nϭ3). In addition, 27 patients with reperfused acute MI underwent CMR for assessment of microvascular dysfunction according to a research protocol that included delayed enhancement imaging. No patient had an implanted cardioverter-defibrillator or pacemaker at the time of imaging. Twenty-three patients (14%) were excluded because of atypical MDE (epicardial or midwall; nϭ5) suggesting myocardial scar due to noncoronary etiologies 24 or technical problems in quantifying the peri-infarct zone of MDE (nϭ18; mostly due to motion artifacts or poor nulling of the normal myocardium). There were no other specific study exclusion criteria, and the remaining 144 patients constituted the study cohort. Medical history was obtained before the CMR examination through patient interview and chart review. We ascertained follow-up vital status by telephone interview, mailed questionnaire, hospital chart review, and query of the National Social Security Death Index. The local institutional ethics review board approved the study.
CMR Protocol
All CMR examinations were performed with a 1.5-T scanner (Signa CV/i, General Electric, Milwaukee, Wis) with the patient in the supine position and a 4-or 8-element phased-array coil placed over the chest. Images were acquired during breath-holds with ECG gating. We used a segmented k-space steady-state free-precession sequence (repetition time, 3.4 ms; echo time, 1.2 ms; in-plane spatial resolution between 1.5ϫ1.8 mm and 1.8ϫ2.1 mm, depending on the field of view) for cine imaging in parallel short-axis (contiguous slices of 8-mm thickness covering the base to apex) and 3 long-axis views of the left ventricle. With a previously described inversionrecovery pulse sequence 25 (repetition time, 4.8 ms; echo time, 1.3 ms; in-plane spatial resolution between 1.5ϫ1.8 mm and 1.8ϫ2.1 mm), delayed enhancement images at matching cine-image slice locations were acquired 10 to 15 minutes after intravenous gadolinium-DTPA administration (0.15 to 0.20 mmol/kg; Magnevist, Berlex Pharmaceuticals, Wayne, NJ). We optimized the inversion time (250 to 350 ms) to null the normal myocardium and adjusted the views per segment and trigger delay according to the patient's heart rate to minimize any image blurring.
CMR Image Analysis
All images were reviewed and analyzed off-line with specialized postprocessing software (Cinetool version 3.9.8, General Electric Healthcare). Collection and interpretation of all imaging data were blinded to the clinical data and outcome. We manually traced the LV endocardial border on all short-axis cine images at the end-diastolic and end-systolic frames to determine the end-diastolic and end-systolic volumes, respectively. LV mass was calculated by subtracting the endocardial volume from the epicardial volume at end diastole and then multiplying by the tissue density (1.05 g/mL). The endocardial and epicardial contours on delayed enhancement images were also outlined manually. Using a semiautomatic detection algorithm, we applied a signal-intensity threshold of Ն2 SDs above a reference remote myocardial region on the same slice to quantify the total infarct mass (MDE total ), 15, [17] [18] [19] 23 , which was partitioned into the strongly enhanced core infarct mass (MDE core ) and the infarct periphery mass (MDE periphery ) based on signal-intensity thresholds of Ͼ3 SDs and 2 to 3 SDs above the remote reference segment, respectively ( Figure 1 ). These thresholds were specified a priori. We also determined the mean transmural extent of the infarct, as previously described. 26 Areas of microvascular obstruction, defined as subendocardial hypoenhanced regions surrounded by hyperenhancement, were included as part of the core infarct (MDE core ). In some cases, manual adjustments were necessary to include the area of microvascular obstruction in the MDE core . Infarct size (%MDE total ) was expressed as a percentage of LV mass. We also normalized MDE periphery and MDE core as percentages of the MDE total according to the following equations: %MDE total ϭ(MDE total /LV mass)ϫ100% %MDE periphery ϭ(MDE periphery /MDE total )ϫ100% %MDE core ϭ(MDE core /MDE total )ϫ100%
The results of %MDE periphery and %MDE core measurements were not communicated to the referring physicians and therefore did not influence any subsequent treatment decision.
Statistical Analysis
Continuous variables are summarized as meanϮSD and were compared by the t test. We used Spearman's rank correlation to examine correlations. Categorical variables are presented as frequency or percentage and were compared by the 2 test (or Fisher exact test, where appropriate). The primary outcome was all-cause mortality; the secondary end point was cardiovascular mortality, which included death due to heart failure, fatal MI, and sudden death. Survival curves were estimated by the Kaplan-Meier method and compared by the log-rank test. Multivariable Cox proportionalhazards models were developed to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). We constructed 2 separate multivariable models to critically assess the incremental prognostic value of %MDE periphery , which was analyzed as a continuous variable. First, we considered %MDE periphery and all of the baseline characteristics associated with mortality by univariable analyses by using forward stepwise selection (PϽ0.10 for entry and PϾ0.05 for removal) criteria to arrive at a parsimonious model. Second, we incorporated %MDE periphery into a multivariable model containing age and LVEF because of their well-established prognostic importance. 27 We examined the regression coefficients for quintiles of %MDE periphery and found no violation of the linearity assumption. The proportionalhazards assumption was verified for all of the explanatory variables in the models. A 2-sided probability value Ͻ0.05 was considered statistically significant. All statistical analyses were conducted with SAS version 9.1 (SAS Institute, Cary, NC).
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscripts as written. Table 1 summarizes the clinical characteristics and CMR findings of the study population. The mean age was 62 years, and the majority of patients were male. All patients in the study cohort had abnormal MDE consistent with MI and clinical and/or angiographic evidence of coronary artery disease. Thirty-six patients (25%) had acute MI (defined as ischemic symptoms with an elevated troponin level within 7 days), 84 (58%) had a history of chronic MI and/or coronary revascularization (percutaneous coronary angioplasty or coronary bypass surgery), and 24 (17%) did not have any clinical history of MI or coronary artery disease but had evidence of MI by abnormal MDE and angiographically significant (Ͼ70%) coronary stenosis. The median age of chronic MI was 2.4 years (range, 5 months to 12 years), and nonacute MI-related coronary revascularization was performed at a median of 3.2 years (range, 9 months to 9 years) before CMR. The median %MDE periphery was 25.8% (interquartile range, 16.6 to 32.5). Patients with %MDE periphery above the median had significantly smaller infarcts and a lower prevalence of abnormal Q waves compared with the group with a %MDEperiphery below the median. %MDE periphery was inversely correlated with %MDE total (Spearman rhoϭϪ0.50, PϽ0.0001). There were no significant correlations between %MDE periphery and LVEF, LV end-diastolic volume index, or LV end-systolic volume index (all PϭNS). Furthermore, %MDE periphery did not demonstrate any significant positive correlation with heart rate (rϭϪ0.14, PϭNS), indicating that it was not related to image blurring due to inadequate temporal resolution.
Results
Follow-up vital status was available for all patients. After a median follow-up of 2.4 years (range, 6 to 53 months), 29 (20%) patients had died. Of these patients, 19 had cardiovascular death; the immediate cause of death in the remaining 10 patients could not be ascertained (4 patients had a history of severe heart failure, 1 had documented ventricular tachycardia, and 5 had cancer). Figure 2 illustrates the Kaplan-Meier survival curves stratified by median %MDE periphery . The risk of death was significantly higher among patients with a %MDE periphery above the median compared with those with a %MDE periphery below the median (28% versus 13%, respectively; HR, 2.74; 95% CI, 1.05 to 0.65; PϽ0.01). When %MDE periphery was analyzed as a continuous variable, the HR for death per 10% increase in %MDE periphery was 1.31 (95% CI, 1.06 to 1.63; Pϭ0.01). Similarly, a greater MDE periphery (absolute mass in grams) was associated with a higher risk of death (HR, 1.06; 95% CI, 1.00 to 1.11; Pϭ0.035). Although there was an inverse correlation between infarct size (%MDE total ) and LVEF (rϭϪ0.48, PϽ0.001), there was no significant association between infarct size and mortality (all-cause or cardiovascular). There was also no significant relation between mean infarct transmural extent and mortality (all-cause or cardiovascular). Table 2 lists the univariable predictors of mortality with PϽ0. 10 . When all of the clinical and imaging parameters associated with mortality on univariable analysis were considered in the multivariable model by stepwise forward selection, %MDE periphery and LV end-systolic volume index emerged as the 2 strongest independent predictors of allcause mortality ( Table 2 ) and cardiovascular mortality. The adjusted HRs for all-cause mortality and cardiovascular mortality were 1.45 (95% CI, 1.15 to 1.84; Pϭ0.002) and 1.51 (95% CI, 1.11 to 2.06; Pϭ0.009), respectively, per 10% increase in %MDE periphery . When patients with acute MI were excluded from the analysis (nϭ108), %MDE periphery and LV end-systolic volume index remained the 2 strongest independent predictors of all-cause mortality and cardiovascular mortality by stepwise forward selection. Adjusted to the effects of LV end-systolic volume index, %MDE periphery maintained a strong, independent association with all-cause mortality (adjusted HR, 1.32 per 10% increase in %MDE periphery ; 95% CI, 1.03 to 1.69; Pϭ0.03) and cardiovascular mortality (adjusted HR, 1.37 per 10% increase in %MDE periphery ; 95% CI, 1.01 to 1.86; PϽ0.05). Similarly, in the multivariable analysis after adjusting for age and LVEF, %MDE periphery remained a powerful, independent predictor of all-cause mortality (adjusted HR, 1.42 per 10% increase; 95% CI, 1.11 to 1.81; Pϭ0.005; Table 2 ) and cardiovascular mortality (adjusted HR, 1.49 per 10% increase; 95% CI, 1.09 to 2.03; Pϭ0.014).
Discussion
The principal finding in this pilot study is that the extent of the peri-infarct zone defined by delayed-enhancement CMR (%MDE periphery ) is an independent predictor of post-MI allcause and cardiovascular mortality, after adjusting for LV volumes or LVEF. To the best of our knowledge, this study 
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is the first to demonstrate that infarct characterization by CMR after the acute phase of MI confers incremental prognostic information for post-MI mortality. Therefore, CMR not only may prove to be a valuable noninvasive tool to improve the risk stratification of post-MI patients but also may provide important insights into the pathophysiological determinants of post-MI risk.
The optimal management of post-MI patients has evolved rapidly during the past few years. Randomized clinical trials have established the efficacy of implantable cardioverterdefibrillator therapy in high-risk patients. 1, 2 Although we observed a significant relation between infarct size and LVEF, as reported in previous studies, 23 infarct size per se was not associated with all-cause mortality. Although this lack of association may reflect the heterogeneous chronicity of MI of the study population or limited study power owing to the relatively small sample size, myriad neurohormonal factors beyond infarct size can mediate ventricular remodeling, arrhythmias, and impact on post-MI clinical outcomes. 28 Consistent with previous studies, 29 we found that LVEF and LV volumes were stronger predictors of all-cause mortality than was infarct size. Although reduced LVEF is frequently used as an eligibility criterion, it has only limited ability to discriminate patients who would benefit from invasive and costly treatments, such as implantable cardioverterdefibrillators. 3, 4 Therefore, supplemental strategies to refine risk assessment are necessary to maximize the benefit-risk ratio and the cost-effectiveness of this potentially life-saving therapy. 4 Our findings suggest that CMR characterization of the peri-infarct zone of less dense MI provides incremental predictive value for survival beyond LV functional parameters. We speculate that this predictive value may reflect the presence and extent of a potentially arrhythmogenic heterogeneous zone of viable and nonviable peri-infarct myocardium.
Animal studies have furnished valuable insights into the potential role of tissue heterogeneity in the development of arrhythmias after MI. Electrical remodeling occurs in the border zone of the infarct, 7, 8 leading to slow conduction that promotes reentrant ventricular tachycardia. Importantly, these experimental observations have been corroborated by pathological studies in humans. Smaller patchy infarcts, which might facilitate the development of complex 3-dimensional reentry circuits, have been documented in patients with chronic infarcts complicated by ventricular tachycardia. 10 Histological examination of myocardial specimens from patients with chronic MI and medically refractory ventricular tachycardia revealed isolated bundles of surviving myocytes interwoven with strands of fibrous tissue at the apparent arrhythmic focus. 9 These findings lend credence to the concept that the reentry pathway is defined by bands of surviving myocytes bordered by dense fibrosis that is often present in the infarct border. 9 -13 Collectively, these data strongly implicate a heterogeneous peri-infarct zone in the pathogenesis of arrhythmias after MI. Theoretically, the excellent spatial resolution afforded by CMR may permit noninvasive evaluation of this critical infarct region. The heterogeneity of signal intensities within the infarct after gadolinium administration observed in the present study may correspond to different infarct zones with variable relative amounts of fibrosis and myocytes. This notion is supported by several lines of evidence. Although the threshold of remote ϩ2 SDs has been validated against triphenyltetrazolium chloride (TTC) staining, 16, 17 it is noteworthy that TTC staining may not detect microscopic foci of surviving myocytes in nonhomogeneous infarcts, where necrotic and viable myocytes intermingle. 30 Because such patchy infarcts are not expected to contribute to functional recovery after revascularization, practically they are considered to be nonviable. Although the transmural extent of delayed hyperenhancement is useful in predicting functional recovery after successful revascularization in clinical practice, it does not exclude the presence of surviving myocytes in a patchy infarct that may serve as an important arrhythmogenic substrate. These "islands" of myocytes may also be at risk for ischemia or reinfarction. Consistent with these postulates, an early study also showed that up to 10% of the hyperenhanced myocardium was viable. 15 Saeed et al 20, 21 found that the gadolinium-enhanced region was larger than the true infarct as delineated by TTC staining, which was identical to regions enhanced by the necrosis-specific contrast agent mesoporphyrin. The difference in enhancement regions demarcated by the 2 contrast agents was considered the peri-infarct zone. 21 Using a rabbit model, Kim et al 16 demonstrated that differential image intensities were primarily related to regional differences in contrast wash-in and wash-out time constants. Of note, the time constants at the infarct rim were significantly different from and intermediate to those in the normal regions and in the infarct core. Finally, in the reperfused myocardium of rat hearts subjected to variable durations of ischemic injury, the fractional distribution of volume of gadodiamide in the peri-infarct rim was significantly greater than that in normal myocardium but lower than that in the infarct core. 31 Therefore, the totality of experimental data strongly suggests the existence of a gradient of changes in contrast kinetics and volume of distribution from the normal myocardium to the infarct center, 15, 16, 20, 21, 31 which likely reflects an increasing proportion of necrotic myocytes. Because the signal intensities before gadolinium administration are similar across the normal and infarcted myocardium, delayed enhancement is thought to arise from regional differences in tissue gadolinium concentration and T1. We therefore postulate that myocardium demonstrating intermediate signal intensity (between 2 SDs and 3 SDs above remote regions) on delayed imaging observed in the present study represents the peri-infarct zone, where the gadolinium concentration was higher than in the normal nulled myocardium but lower compared with the infarct core. Notably, this peri-infarct zone is not necessarily confined to the border of the infarct (Figure 3 ), but heterogeneous signal intensity can be seen in more central locations, consistent with surviving myocyte bands in central, subendocardial, and subepicardial locations in infarcts associated with ventricular tachycardia. 9, 11, 13 Partial-volume effect may also have contributed to the intermediate signal intensity in the periphery of the infarct. In an animal model, a similar intermediate signal intensity was reported along the periphery of the hyperenhanced zone due to partial-volume effect of the complex 3-dimensional structure of the infarct. 17 Because the views per segment was adjusted according to heart rate, which was not correlated with %MDE periphery , the intermediate signal intensities that we observed probably represented the true 3-dimensional complexity of the infarct structure rather than edge blurring due to limited temporal resolution. In a recent study by Bello et al, 23 infarct surface area and mass defined by CMR delayed enhancement were better predictors of inducible ventricular tachycardia during electrophysiological study than LVEF. These authors did not assess the heterogeneity of delayed hyperenhancement. It should also be recognized that although electrophysiological study detects the presence of the relatively fixed reentry substrate, it may not predict arrhythmias that depend on autonomic and neurohormonal modulating factors or myocyte ischemia in the peri-infarct region. By demonstrating that %MDE periphery is an independent predictor of mortality incremental to LVEF, our results extend previous work and provide further support that morphologically complex infarcts may portend a worse outcome. Although we recognize that partial-volume effect is a limitation of voxel resolution to maintain an adequate signal-to-noise ratio, delayed enhancement intensity may be used as a unique surrogate marker of infarct complexity pending further advances in CMR technology.
Limitations
Several study limitations should be considered in the interpretation of our findings. First, this pilot study included only a relatively small number of patients enrolled in a singlecenter setting. Our results require confirmation by larger, prospective studies. The relatively high mortality rate may also reflect potential selection bias influenced by the local CMR referral pattern. Therefore, the generalizability of our findings to less-selected post-MI patient populations needs to be established. Second, because the time of MI could not be ascertained in a minority of patients in this pilot cohort, any potential relation between infarct age and the characteristics of the peri-infarct zone by CMR cannot be determined. Third, we used a prespecified, arbitrary signal-intensity threshold (remoteϩ3 SDs) to delineate the core infarct on delayedenhancement imaging, although the chosen cutoff of remote ϩ2 SDs for the entire infarct has been previously validated in animal models 15, 17 and applied in various clinical studies. 18, 19, 23 Future studies should determine the optimal signalintensity thresholds for more accurate infarct characterization. Finally, we do not know the immediate cause of death or whether death was sudden or arrhythmic for some patients. It is recognized, however, that details about immediate cause of death are often inherently inaccurate, and all-cause mortality is a more robust end point that has been widely accepted, even in clinical trials of implantable cardioverter-defibrillators. 1, 2 
Study Implications
Although this study does not provide insights into the exact histological basis of different infarct characteristics on CMR (isolated strands of surviving myocytes within the infarct border or complex 3-dimensional infarct morphology) or the pathophysiological mechanisms leading to adverse clinical outcomes, our study raises several important questions that may have profound therapeutic implications and deserve further investigations. For instance, the existence of viable myocytes in a large peri-infarct zone may raise the interesting hypothesis that revascularization could be beneficial by reducing arrhythmogenic triggers, despite the apparent lack of measurable improvement in contractile function. Alternatively, implantable cardioverter-defibrillator therapy may be warranted in such high-risk patients identified by CMR owing to the potential for multiple reentry circuits in the peri-infarct zone, even if LV function is preserved.
Conclusions
In conclusion, this pilot study demonstrates that the extent of the peri-infarct region detected by contrast-enhanced CMR is an independent predictor of all-cause mortality after MI, even after adjustment for LV systolic volume index or LVEF. If these results are confirmed, CMR may become a valuable noninvasive risk-stratification tool to guide the optimal use of therapies tailored to individual post-MI patients. Further studies are warranted to elucidate the histological basis of the peri-infarct zone, the pathophysiological links to unfavorable outcome, and their therapeutic implications.
